Literature DB >> 15061705

HLA typing in Taiwanese patients with oral submucous fibrosis.

Hsin-Ming Chen1, Rhong-Phong Hsieh, Hsiang Yang, Ying-Shiung Kuo, Mark Yen-Ping Kuo, Chun-Pin Chiang.   

Abstract

BACKGROUND: A significant association of certain human leukocyte antigens (HLA) and haplotypic pairs with oral submucous fibrosis (OSF) has been reported. However, controversial result of no HLA association with OSF has also been reported. In this study, the phenotype and haplotype frequencies of HLA-A, -B, -C, -DRB1, and -DQB1 in 135 Taiwanese OSF patients were calculated and compared with those in 540 healthy control Taiwanese.
METHODS: The analysis of HLA-A, -B, and -C antigens, and of HLA-DRB1 and -DQB1 alleles in OSF patients and healthy control subjects, was performed by serologic typing and DNA typing using polymerase chain reaction with sequence-specific primers (PCR-SSP), respectively.
RESULTS: We found that the phenotype frequency of HLA-B76 (3.0%) in OSF patients was significantly greater than that (0%) in healthy control subjects (corrected P (Pc) = 0.000). In addition, the haplotype frequencies of HLA-B48/Cw7 (3.0%), -B51/Cw7 (6.7%), and -B62/Cw7 (8.2%) in OSF patients were significantly greater than the corresponding haplotype frequencies (0, 0.7, and 1.9%, respectively) in healthy control subjects (Pc = 0.000). The relative risk (RR) values of haplotypes B51/Cw7 (9.57) and B62/Cw7 (4.7) were greater than the RR values of phenotypes B51 (1.81), B62 (2.31), and Cw7 (1.91) in OSF patients. In addition, the etiologic fraction (EF) value of haplotype B51/Cw7 (0.63) was higher than the EF values of phenotypes B51 (0.2) and Cw7 (0.59).
CONCLUSIONS: We conclude that some Taiwanese areca quid (AQ) chewers with particular HLA phenotypes and haplotypes are prone to have OSF. In addition, some particular HLA haplotypes may play more important roles than the individual HLA phenotypes for the genetic susceptibility to OSF. However, the significantly increased HLA phenotype B76 and three of the common HLA haplotypes detected are present in only about 20% of incident cases of OSF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061705     DOI: 10.1111/j.0904-2512.2004.00195.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

Review 1.  Management of oral submucous fibrosis: an overview.

Authors:  Punnya V Angadi; Sanjay Rao
Journal:  Oral Maxillofac Surg       Date:  2010-09

2.  Cys-X-Cys ligand 9 might be an immunological factor in the pathogenesis of oral submucous fibrosis and its concomitant oral lichenoid lesion.

Authors:  Ning Li; Qiong Hu; Canhua Jiang; Feng Guo; Krishna Munnee; Xinchun Jian; Yanjia Hu; Zhangui Tang
Journal:  Clin Oral Investig       Date:  2012-07-21       Impact factor: 3.573

Review 3.  Areca nut in pathogenesis of oral submucous fibrosis: revisited.

Authors:  Punnya V Angadi; Sanjay S Rao
Journal:  Oral Maxillofac Surg       Date:  2011-03

4.  Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.

Authors:  Lian Zheng; Zhen-Jie Guan; Wen-Ting Pan; Tian-Feng Du; Yu-Jia Zhai; Jia Guo
Journal:  Oncol Res       Date:  2017-05-21       Impact factor: 5.574

5.  Characterization of anti-nuclear antibodies in patients with oral submucous fibrosis and its clinicopathologic implications - An immunofluorescence study.

Authors:  Aprna Gupta; Surya Narayan Das; Bijoy Kumar Das; Lipsa Bhuyan
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.